Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Category: NICE
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause